Lupin Boosts UK Presence Through Renascience Acquisition
The Acquisition Adds A Fourth-Generation Cephalosporin Antibiotic Into Lupin’s Portfolio
Wockhardt’s UK business sees a 14% growth in quarterly sales and 13% growth in annual sales • Source: Alamy 
